The Fringe Benefits of Cloning Cancer

See allHide authors and affiliations

Science Translational Medicine  17 Sep 2014:
Vol. 6, Issue 254, pp. 254fs36
DOI: 10.1126/scitranslmed.3010174

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


A new approach to monitoring tumor clone dynamics (Carreira et al., this issue) uses sequential biopsies and circulating DNA to help optimize treatment in metastatic prostate cancer.

View Full Text

Stay Connected to Science Translational Medicine

Editor's Blog